Dr Yukiko Nakatani: key facts
- Kind of voice
- Academic
- Role
- WHO Assistant Director-General for Health Systems
- Quoted on
- Rare diseases
- Press citations held
- 1
- Most recently quoted
- 30 Sept 2026
“Antimicrobial resistance is escalating. But the pipeline of new treatments and diagnostics is insufficient. Without more investment in R&D, together with dedicated efforts to ensure that new and existing products reach the people who most need them, drug-resistant infections will continue to spread.”
Where Dr Yukiko Nakatani has been quoted
- Pharma is politics now: Antibiotic resistance and orphan drugs in EU spotlighteuperspectives.eu · 30 Sept 2026
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 30 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.